Aerogen has been at the forefront of medical response to the pandemic with our products being used with over 3 million hospitalized and critically ill patients since March 2020.
As much of the world’s industry and services were shutting down Aerogen was rapidly increasing staff numbers and moving to 24/7 manufacturing, effectively doubling our product output capability – ensuring first and foremost that ‘no patient should go without’.It is a great honour to have been shortlisted by the Irish Medtech Association in the Covid-19 Response Recognition Award category.
